Technical analysis is an important tool for evaluating the performance of a stock, and Innoviva Inc (INVA) is no exception. By analyzing various technical indicators, investors can gain insights into the stock's current and future trends. One such indicator is the Relative Strength Index (RSI), which measures the speed and change of price movements. It can help identify overbought or oversold levels, indicating possible buying or selling opportunities.

Another useful indicator is the Average Directional Index (ADX), which measures the strength of a stock's trend. A high ADX value suggests a strong trend, while a low value indicates a weak or sideways trend. By combining the RSI and ADX, investors can get a comprehensive view of the stock's momentum and direction.

Innoviva  (INVA) Technical Analysis

Learn about Innoviva Inc (INVA) technical analysis through various indicators such as RSI, ADX, and MACD. Get insights into the stock's performance and trends. Understand the stock's Rate of Change (ROC), STOCHRSI, and WILLR. Gain valuable information for your investment decisions.

Innoviva Inc (INVA) Technical Analysis: Indicators, RSI, ADX, MACD

Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

Innoviva 

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	59.84	Neutral	-
auto_graphMACD	-0.48	Neutral	-15.6%
auto_graphCCI	280.25	Sell	-70.2%
auto_graphADX	21.37	Neutral	-
auto_graphATR	1.02	Neutral	-
auto_graphWILLR	-29.83	Neutral	-70.2%
auto_graphROC	116.02	Neutral	48.9%
auto_graphSTOCHRSI	100.00	Sell	-77.3%

Buy	0	-100.00%
Hold	6	-25.00%
Sell	2	-75.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Innoviva (INVA) Technical Analysis

Keep an eye on Innoviva

Frequently Asked Questions

What are the technical signals for Innoviva (INVA) stock based on the last 30 days?

Take Your Investments to a Whole New Level